Rockefeller Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.3M | Sell |
254,322
-143,408
| -36% | -$12.8M | 0.04% | 397 |
|
|
2026
Q1 | $28.6M | Buy |
397,730
+96,960
| +32% | +$7.47M | 0.05% | 349 |
|
|
2025
Q4 | $23.9M | Sell |
300,770
-8,624
| -3% | -$680K | 0.04% | 398 |
|
|
2025
Q3 | $23.3M | Buy |
309,394
+2,351
| +0.8% | +$161K | 0.05% | 367 |
|
|
2025
Q2 | $21.2M | Sell |
307,043
-55,614
| -15% | -$3.65M | 0.05% | 368 |
|
|
2025
Q1 | $24.6M | Sell |
362,657
-61,724
| -15% | -$3.69M | 0.06% | 298 |
|
|
2024
Q4 | $19.1M | Sell |
424,381
-179,651
| -30% | -$10.1M | 0.05% | 355 |
|
|
2024
Q3 | $38M | Sell |
604,032
-36,941
| -6% | -$2.16M | 0.1% | 201 |
|
|
2024
Q2 | $37.9M | Sell |
640,973
-62,106
| -9% | -$3.88M | 0.11% | 184 |
|
|
2024
Q1 | $56.1M | Buy |
703,079
+254
| +0% | +$19.4K | 0.16% | 132 |
|
|
2023
Q4 | $55.5M | Sell |
702,825
-106,364
| -13% | -$7.57M | 0.19% | 127 |
|
|
2023
Q3 | $56.5M | Sell |
809,189
-54,242
| -6% | -$3.84M | 0.22% | 110 |
|
|
2023
Q2 | $58.5M | Buy |
863,431
+28,426
| +3% | +$2.02M | 0.23% | 104 |
|
|
2023
Q1 | $62M | Buy |
835,005
+58,401
| +8% | +$4.9M | 0.27% | 92 |
|
|
2022
Q4 | $72.4M | Buy |
776,604
+37,725
| +5% | +$3.64M | 0.36% | 63 |
|
|
2022
Q3 | $70.5M | Buy |
738,879
+215,677
| +41% | +$21.3M | 0.36% | 66 |
|
|
2022
Q2 | $48.5M | Sell |
523,202
-22,549
| -4% | -$2.2M | 0.26% | 86 |
|
|
2022
Q1 | $55.2M | Buy |
545,751
+9,800
| +2% | +$1.03M | 0.27% | 88 |
|
|
2021
Q4 | $55.3M | Sell |
535,951
-1,757
| -0.3% | -$162K | 0.26% | 90 |
|
|
2021
Q3 | $45.6M | Buy |
537,708
+86,624
| +19% | +$7.26M | 0.24% | 98 |
|
|
2021
Q2 | $37.6M | Buy |
451,084
+148,043
| +49% | +$12.1M | 0.21% | 110 |
|
|
2021
Q1 | $22.8M | Buy |
303,041
+8,998
| +3% | +$655K | 0.15% | 153 |
|
|
2020
Q4 | $20.1M | Buy |
294,043
+37,145
| +14% | +$2.42M | 0.15% | 153 |
|
|
2020
Q3 | $15M | Buy |
256,898
+5,836
| +2% | +$363K | 0.14% | 153 |
|
|
2020
Q2 | $16.3M | Sell |
251,062
-9,009
| -3% | -$567K | 0.17% | 137 |
|
|
2020
Q1 | $15.4M | Sell |
260,071
-1,408,179
| -84% | -$94M | 0.2% | 109 |
|
|
2019
Q4 | $124M | Sell |
1,668,250
-329,588
| -16% | -$23.1M | 1.55% | 11 |
|
|
2019
Q3 | $126M | Buy |
1,997,838
+16,242
| +0.8% | +$962K | 1.71% | 13 |
|
|
2019
Q2 | $108M | Buy |
1,981,596
+19,866
| +1% | +$1.07M | 1.51% | 16 |
|
|
2019
Q1 | $106M | Buy |
1,961,730
+219,877
| +13% | +$13.6M | 1.51% | 18 |
|
|
2018
Q4 | $114M | Buy |
1,741,853
+155,431
| +10% | +$11.6M | 2% | 14 |
|
|
2018
Q3 | $125M | Sell |
1,586,422
-7,225
| -0.5% | -$517K | 1.9% | 15 |
|
|
2018
Q2 | $103M | Sell |
1,593,647
-29,888
| -2% | -$1.97M | 1.67% | 18 |
|
|
2018
Q1 | $101M | Buy |
+1,623,535
| New | +$116M | 1.67% | 18 |
|
Other funds holding CVS
Rockefeller Capital Management's CVS Position: Q2 2026 in Review
Rockefeller Capital Management reduced its CVS Health (CVS) stake by 36% in Q2 2026, selling an estimated $12.8M and leaving 254,322 shares worth $26.3M. The position accounts for 0.04% of the portfolio, ranked #397.
Rockefeller Capital Management first reported a position in CVS in Q1 2018 and has held it in 34 quarters since. The position peaked at $126M in Q3 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Rockefeller Capital Management held 254,322 shares of CVS Health worth $26.3M as of Q2 2026.
- Rockefeller Capital Management sold 143,408 CVS Health shares in Q2 2026, an estimated $12.8M.
- CVS Health made up 0.04% of Rockefeller Capital Management's portfolio in Q2 2026, its #397 holding.
- Rockefeller Capital Management first reported a position in CVS Health in Q1 2018 and has held it in 34 quarters since.
- Rockefeller Capital Management's CVS Health position peaked at $126M in Q3 2019.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.